Sosei
2009.12.25
Sosei Announces Expiration of Stock Acquisition Rights
2009.11.12
Announcement of Financial Results for the 1st Half ended 30 Sep. 2009 (April-Sep. 2009)
2010.01.06
Update on Phase I Clinical Study of RS(+) Mefloquine for Malaria
2009.11.12
Summary of Consolidated Financial Results for the First Half Year ended 30th September 2009 (abridged English version)
2009.11.02
Sosei Signs Definitive Distribution Agreement with ASKA for Commercialisation of SOH-075 (NorLevo®)
2009.10.22
Update on NVA237 and QVA149 for Chronic Obstructive Pulmonary Disease
For past news and financial reports, please go to
News
and
Financial Data
.